Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 23488905)

1.

Developing novel biopharmaceutical products through morphogenics.

Nicolaides NC, Sass PM, Chao Q, Kline JB, Ebel W, Routhier E, Zhou Y, Grasso L.

Expert Opin Drug Discov. 2007 Dec;2(12):1619-29. doi: 10.1517/17460441.2.12.1619.

PMID:
23488905
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

Morphogenics as a tool for target discovery and drug development.

Nicolaides NC, Ebel W, Kline B, Chao Q, Routhier E, Sass PM, Grasso L.

Ann N Y Acad Sci. 2005 Nov;1059:86-96. Review.

PMID:
16382047
4.

Recent progress in biomolecular engineering.

Ryu DD, Nam DH.

Biotechnol Prog. 2000 Jan-Feb;16(1):2-16. Review.

PMID:
10662483
5.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
6.

Advances in targeted therapeutic agents.

Nicolaides NC, Sass PM, Grasso L.

Expert Opin Drug Discov. 2010 Nov;5(11):1123-40. doi: 10.1517/17460441.2010.521496. Epub 2010 Oct 1. Review.

PMID:
22827748
7.

Use of lipid-based nutrient supplements (LNS) to improve the nutrient adequacy of general food distribution rations for vulnerable sub-groups in emergency settings.

Chaparro CM, Dewey KG.

Matern Child Nutr. 2010 Jan;6 Suppl 1:1-69. doi: 10.1111/j.1740-8709.2009.00224.x.

PMID:
20055936
8.
9.

Preclinical development strategies for novel gene therapeutic products.

Pilaro AM, Serabian MA.

Toxicol Pathol. 1999 Jan-Feb;27(1):4-7. Review.

10.

[Prospects for development of new antituberculous drugs].

Tomioka H.

Kekkaku. 2002 Aug;77(8):573-84. Japanese.

PMID:
12235850
11.

Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.

Aardema MJ, MacGregor JT.

Mutat Res. 2002 Jan 29;499(1):13-25. Review.

PMID:
11804602
12.

The promise of genomics to identify novel therapeutic targets.

Orth AP, Batalov S, Perrone M, Chanda SK.

Expert Opin Ther Targets. 2004 Dec;8(6):587-96. Review.

PMID:
15584864
13.

The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases--a review.

Basso LA, da Silva LH, Fett-Neto AG, de Azevedo WF Jr, Moreira Ide S, Palma MS, Calixto JB, Astolfi Filho S, dos Santos RR, Soares MB, Santos DS.

Mem Inst Oswaldo Cruz. 2005 Oct;100(6):475-506. Epub 2005 Nov 8. Review.

14.

Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.

Lu H, Tonge PJ.

Acc Chem Res. 2008 Jan;41(1):11-20. doi: 10.1021/ar700156e. Review.

PMID:
18193820
15.

High impact technologies for natural products screening.

Koehn FE.

Prog Drug Res. 2008;65:175, 177-210. Review.

PMID:
18084916
16.

Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery.

Berger AB, Vitorino PM, Bogyo M.

Am J Pharmacogenomics. 2004;4(6):371-81. Review.

PMID:
15651898
17.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
18.

Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.

Cho CH, Nuttall ME.

Expert Opin Ther Targets. 2002 Dec;6(6):679-89. Review.

PMID:
12472380
19.

Novel antibacterials: a genomics approach to drug discovery.

Chan PF, Macarron R, Payne DJ, Zalacain M, Holmes DJ.

Curr Drug Targets Infect Disord. 2002 Dec;2(4):291-308. Review.

PMID:
12570737
20.

Upflow anaerobic sludge blanket reactor--a review.

Bal AS, Dhagat NN.

Indian J Environ Health. 2001 Apr;43(2):1-82. Review.

PMID:
12397675
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk